Office of the Assistant Secretary for Planning and Evaluation OASPE Influenza Vaccine Project: Under

1
Office of the Assistant Secretary for Planning
and Evaluation (OASPE) Influenza Vaccine Project
Understanding the Dynamics of Influenza Vaccine
Supply and Demand
Presented to National Vaccine Advisory Committee
Washington, DC February 8, 2005 Presented by
Christine M. Layton, PhD, MPH
1615 M Street, NW, Suite 740 Washington, DC
20036Phone [phone] layton_at_rti.org
www.rti.org RTI International is a trade name of
Research Triangle Institute.
2
Introduction

• Project follows up previous project Annual
  Influenza Vaccine Distribution Process concluded
  in 2001.
• Purpose of present project is to review the
  current status of influenza vaccine demand,
  supply and distribution.
• Five (5) issue briefs will be produced by the end
  of 2005.

3
Summary of Previous Project Annual Influenza
Vaccine Distribution Process

• Investigated influenza vaccine distribution in
  2000-2001 season focusing on
• Vaccine distributors
• Mass immunizers
• Non-traditional providers
• Economic factors

4
Summary of Previous Project Annual Influenza
Vaccine Distribution Process

• Findings
• Delays in distribution of influenza vaccine in
  2000-2001 due to multiple causes
• Notably
• Too few manufactures
• Too little vaccine
• Too late

5
Purpose of Current Project

• To provide policy makers and other decision
  makers information about influenza vaccine issues
  that
• Summarizes current issues
• Is in a useful format

6
Summary of Current Project Understanding the
Dynamics of Influenza Vaccine Supply and Demand

• Annotated bibliography
• Key informant interviews
• Issue briefs
• Influenza vaccine overview
• Influenza vaccine purchasing and distribution
• Influenza vaccine manufacturing
• Influenza vaccine economics
• TBD

7
RTI Staff

• Dr. Amanda HoneycuttEconomic analyst
• Dr. Christine LaytonProject leader
• Dr. David ReinEconomic analyst
• Adrienne RooksCoordinator
• Dr. Lucia Rojas SmithResearch analyst
• Nathan WestProject associate

8
Project Timeline

• Briefing reports will be completed between April
  and September 2005
• Influenza vaccine purchasing and distribution --
  April
• Influenza vaccine manufacturing -- May
• Influenza vaccine economics -- May
• Influenza vaccine overview -- August
• TBD -- September

9
Annotated Bibliography

• Collecting various sources of information
• Peer-reviewed journals
• Expert reports, e.g., IOM
• Fugitive literature
• Websites
• Conference abstracts
• Print media, i.e., newspapers

10
Key Informant Interviews

• Interviewees will include
• Vaccine manufactures
• Vaccine distributors
• Federal experts
• Other experts

11
Issue Brief Overview

• Summarize influenza vaccine supply issues
• Update information presented in previous project
• Summarize other issue briefs
• Provide case studies for previous influenza
  seasons 2003-2005.

12
Issue Brief Influenza Vaccine Purchasing and
Distribution

• Role of purchasers
• Role of distributors
• Role of other participants

13
Issue Brief Vaccine Manufacturers

• Structure of industry
• Nature of influenza vaccine market
• Global market factors
• Decision making regarding
• Quantity to produce
• Investments in new technologies

14
Issue Brief Influenza Vaccine Economics

• Costs of production
• Pricing strategies
• Factors that impact consumer decisions to
  purchase vaccine

15
Issue Brief TBD

• List of potential topics due to OASPE in March
• Ideas or other comments may e-mailed to
  layton_at_rti.org or amy.nevel_at_hhs.gov